Literature DB >> 10757064

Vascular damage after photodynamic therapy of solid tumors: a view and comparison of effect in pre-clinical and clinical models at the University of Louisville.

V H Fingar1, S W Taber, P S Haydon, L T Harrison, S J Kempf, T J Wieman.   

Abstract

Microvascular damage that results in blood flow stasis is a frequent consequence of photodynamic therapy. The magnitude of this response is dependent on the type of photosensitizer employed for treatment, the amount of drug and light used in therapy and the time period between drug injection and treatment. This review highlights the mechanisms that lead to blood flow stasis in tumor and normal tissues and discusses methods to increase the selectivity of vascular response.

Entities:  

Mesh:

Year:  2000        PMID: 10757064

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  11 in total

Review 1.  Photodynamic therapy in head and neck cancer.

Authors:  Merrill A Biel
Journal:  Curr Oncol Rep       Date:  2002-01       Impact factor: 5.075

2.  Increasing damage to tumor blood vessels during motexafin lutetium-PDT through use of low fluence rate.

Authors:  Theresa M Busch; Hsing-Wen Wang; E Paul Wileyto; Guoqiang Yu; Ralph M Bunte
Journal:  Radiat Res       Date:  2010-09       Impact factor: 2.841

Review 3.  Endoscopic Management of Pancreatobiliary Malignancies.

Authors:  Dong Wook Lee; Eun Young Kim
Journal:  Dig Dis Sci       Date:  2022-02-16       Impact factor: 3.199

4.  Neuropilin-1 targeting photosensitization-induced early stages of thrombosis via tissue factor release.

Authors:  Denise Bechet; Loraine Tirand; Béatrice Faivre; François Plénat; Corinne Bonnet; Thierry Bastogne; Céline Frochot; François Guillemin; Muriel Barberi-Heyob
Journal:  Pharm Res       Date:  2010-01-20       Impact factor: 4.200

5.  Hypericin-mediated photodynamic therapy of pituitary tumors: preclinical study in a GH4C1 rat tumor model.

Authors:  Chad D Cole; James K Liu; Xiaoming Sheng; Steven S Chin; Meic H Schmidt; Martin H Weiss; William T Couldwell
Journal:  J Neurooncol       Date:  2008-01-29       Impact factor: 4.130

Review 6.  Management options for malignant pleural mesothelioma: clinical and cost considerations.

Authors:  Ranjit K Goudar
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 7.  New therapeutic options for mesothelioma.

Authors:  Ranjit Kumar Goudar
Journal:  Curr Oncol Rep       Date:  2005-07       Impact factor: 5.945

8.  Tumor blood flow differs between mouse strains: consequences for vasoresponse to photodynamic therapy.

Authors:  Rickson C Mesquita; Sung Wan Han; Joann Miller; Steven S Schenkel; Andrew Pole; Tatiana V Esipova; Sergei A Vinogradov; Mary E Putt; Arjun G Yodh; Theresa M Busch
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

9.  Multifunctional Peptide-conjugated hybrid silica nanoparticles for photodynamic therapy and MRI.

Authors:  Hamanou Benachour; Aymeric Sève; Thierry Bastogne; Céline Frochot; Régis Vanderesse; Jordane Jasniewski; Imen Miladi; Claire Billotey; Olivier Tillement; François Lux; Muriel Barberi-Heyob
Journal:  Theranostics       Date:  2012-09-29       Impact factor: 11.556

10.  Enhanced effects of aminolaevulinic acid-based photodynamic therapy through local hyperthermia in rat tumours.

Authors:  D K Kelleher; J Bastian; O Thews; P Vaupel
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.